Incidence of Secondary Cancer Development After High-Dose Intensity-Modulated Radiotherapy and Image-Guided Brachytherapy for the Treatment of Localized Prostate Cancer-Reference-Cited by-同舟云学术

Incidence of Secondary Cancer Development After High-Dose Intensity-Modulated Radiotherapy and Image-Guided Brachytherapy for the Treatment of Localized Prostate Cancer

Published:2012-07 Issue:3 Volume:83 Page:953-959
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Zelefsky Michael J.,Housman Douglas M.,Pei Xin,Alicikus Zumre,Magsanoc Juan Martin,Dauer Lawrence T.,St. Germain Jean,Yamada Yoshiya,Kollmeier Marisa,Cox Brett,Zhang Zhigang

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference38 articles.

1. Secondary malignancies across the age spectrum;Ng;Semin Radiat Oncol,2010

2. Subsequent malignant neoplasms in cancer survivors;Ng;Cancer J,2008

3. The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984–2000;Pickles;Radiother Oncol,2002

4. Higher than expected association of clinical prostate and bladder cancers;Singh;J Urol,2005

5. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery;Brenner;Cancer,2000

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mortality from prostate cancer in the years 2007–2021 in North Rhine-Westphalia, Germany;BMC Urology;2024-08-27

2. Mortality from prostate cancer in the years 2007-2021 in North Rhine-Westphalia, Germany;2024-07-13

3. Long-Term Second Malignancies in Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy and Radical Prostatectomy;Journal of Urology;2024-07

4. La radiothérapie du cancer de la prostate augmente-t-elle le risque de seconds cancers ?;Cancer/Radiothérapie;2024-06

5. Skin Malignancies Due to Anti-Cancer Therapies;Cancers;2024-05-22